Milrinone

A phosphodiesterase inhibitor that increases the heart's pumping strength and decreases pulmonary vascular resistance (inotrope and vasodilator).

Dosage by Body Weight

Pediatric loading dose: 50 mcg/kg over 10-60 mins, followed by a continuous infusion of 0.25 to 0.75 mcg/kg/min.

Weight-based dosage tracking table for Milrinone, including body weight, dose, frequency, and tracking notes.
Body Weight	Dose	Frequency	Tracking Notes
Infants/Children	Continuous Infusion	Constant	Monitor blood pressure closely for hypotension (low BP).

Injection

Short-term management of acute heart failure or post-cardiac surgery support.

Milrinone is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:

Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.

CAUTION

Milrinone: Alcohol can increase dizziness, low blood pressure, dehydration, or heart rhythm symptoms. Avoid or limit alcohol.

CAUTION

Milrinone: Use in pregnancy only when prescribed; some heart or blood pressure medicines are not suitable during pregnancy.

SAFE IF PRESCRIBED

Milrinone: Use while breastfeeding only with healthcare provider guidance, as infant monitoring may be needed.

CAUTION

Milrinone: May cause dizziness, faintness, tiredness, or blurred vision, especially when starting or changing dose. Avoid driving if affected.

CAUTION

Milrinone: Liver disease may alter medicine handling and increase side effects. Use with medical supervision.

CAUTION

Milrinone: Kidney function and electrolytes may need monitoring, especially with diuretics, ACE inhibitors, ARBs, or digoxin.